BioStem Technologies, Inc. (BSEM) Financial Statements
$2.64OTC: BSEMMarket Cap $44.84M
BioStem Technologies, Inc. most recently reported annual revenue of $47.0M, net profit of $-7.0M, revenue has compounded at 73.4% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.